Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 4
1997 5
1998 5
1999 1
2000 4
2001 6
2002 10
2003 2
2004 7
2005 7
2006 7
2007 4
2008 8
2009 6
2010 9
2011 13
2012 8
2013 7
2014 23
2015 16
2016 13
2017 13
2018 16
2019 14
2020 15
2021 22
2022 21
2023 22
2024 18
2025 15
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

301 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19: Find the Right Questions to be Answered.
Giacomelli A, Antinori S, Gori A, Cozzi-Lepri A. Giacomelli A, et al. Among authors: cozzi lepri a. Clin Infect Dis. 2024 Nov 22;79(5):1322-1323. doi: 10.1093/cid/ciae078. Clin Infect Dis. 2024. PMID: 38366987 Free article. No abstract available.
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort.
Vergori A, Cozzi-Lepri A, Lo Caputo S, Tavelli A, Mazzotta V, Schiaroli E, Orofino G, Mussini C, Nozza S, Cingolani A, Antinori A, d'Arminio Monforte A; Icona Foundation Study Group. Vergori A, et al. Among authors: cozzi lepri a. J Antimicrob Chemother. 2025 Nov 4;80(11):3082-3091. doi: 10.1093/jac/dkaf345. J Antimicrob Chemother. 2025. PMID: 40985146 Free PMC article.
Multiple viral infections.
Gaeta GB, Precone DF, Cozzi-Lepri A, Cicconi P, D'Arminio Monforte A. Gaeta GB, et al. Among authors: cozzi lepri a. J Hepatol. 2006;44(1 Suppl):S108-13. doi: 10.1016/j.jhep.2005.11.023. Epub 2005 Nov 28. J Hepatol. 2006. PMID: 16352369 Review.
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation.
Mussini C, Giacomelli A, Quiros-Roldan E, Mazzotta V, Di Biagio A, De Vito A, Costantini A, D'Ettorre G, Giacometti A, Vergori A, Tavelli A, Malagnino V, Castagna A, Chester J, Antinori A, d'Arminio Monforte A, Cozzi-Lepri A; Icona Foundation Cohort Study for the Icona Foundation Study Group. Mussini C, et al. Among authors: cozzi lepri a. EClinicalMedicine. 2025 Jul 24;86:103368. doi: 10.1016/j.eclinm.2025.103368. eCollection 2025 Aug. EClinicalMedicine. 2025. PMID: 40740293 Free PMC article.
Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort.
Vergori A, Cervo A, Roen A, Gagliardini R, Clemente T, Mazzotta V, Quiros-Roldan E, Maggiolo F, Lo Caputo S, Mussini C, Antinori A, Cozzi-Lepri A; ICONA Foundation Study. Vergori A, et al. Among authors: cozzi lepri a. Open Forum Infect Dis. 2026 May 13;13(5):ofag250. doi: 10.1093/ofid/ofag250. eCollection 2026 May. Open Forum Infect Dis. 2026. PMID: 42169694 Free PMC article. Clinical Trial.
Reply to Manfredi.
Lichtner M, Vita S, Cozzi Lepri A, d'Arminio Monforte A; ICONA Foundation Study. Lichtner M, et al. Among authors: cozzi lepri a. J Infect Dis. 2015 Apr 15;211(8):1357-9. doi: 10.1093/infdis/jiu618. Epub 2014 Nov 7. J Infect Dis. 2015. PMID: 25381368 Free PMC article. No abstract available.
Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study.
Mussini C, Giacomelli A, Lapadula G, Di Biagio A, Gori A, Orofino G, Quiros-Roldan E, Cingolani A, Madeddu G, Mazzotta V, Rossotti R, Lo Caputo S, Marchetti G, Chester J, Monforte AD, Guaraldi G, Cozzi-Lepri A; Italian Cohort Naive Antiretrovirals (Icona) Foundation study for the Icona Foundation Study Groupt; Italian Cohort Naive Antiretrovirals (Icona) Foundation study for the Icona Foundation Study Group. Mussini C, et al. Among authors: cozzi lepri a. EClinicalMedicine. 2026 Aug 15;99:104150. doi: 10.1016/j.eclinm.2026.104150. eCollection 2026 Sep. EClinicalMedicine. 2026. PMID: 42633417 Free PMC article.
SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH.
Vergori A, Cozzi-Lepri A, Matusali G, Colavita F, Cicalini S, Gallì P, Garbuglia AR, Fusto M, Puro V, Maggi F, Girardi E, Vaia F, Antinori A; HIV-VAC Study Group. Vergori A, et al. Among authors: cozzi lepri a. Viruses. 2022 Aug 3;14(8):1710. doi: 10.3390/v14081710. Viruses. 2022. PMID: 36016332 Free PMC article.
Long-term trajectories of hepatic and metabolic biomarkers after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral therapy-experienced people with HIV with and without hepatic coinfection: Data from the ICONA cohort.
Poliseno M, Caputo SL, Tavelli A, Gagliardini R, Gazzola L, Saracino A, Santantonio TA, Squillace N, Puoti M, Mazzotta V, Antinori A, d'Arminio Monforte A, Cozzi-Lepri A. Poliseno M, et al. Among authors: cozzi lepri a. Int J Infect Dis. 2025 Dec;161:108081. doi: 10.1016/j.ijid.2025.108081. Epub 2025 Oct 4. Int J Infect Dis. 2025. PMID: 41052697 Free article.
301 results